Improvement of glycaemia and endothelial function by a new low-dose curcuminoid in an animal model of type 2 diabetes
Curcumin has been suggested as a promising treatment for metabolic diseases, but the high doses required limit its therapeutic use. In this study, a new curcuminoid is synthesised to increase curcumin anti-inflammatory and antioxidant potential and to achieve hypoglycaemic and protective vascular ef...
Main Author: | |
---|---|
Other Authors: | , , , , , , , , , , |
Format: | article |
Language: | eng |
Published: |
2022
|
Subjects: | |
Online Access: | http://hdl.handle.net/10400.21/14719 |
Country: | Portugal |
Oai: | oai:repositorio.ipl.pt:10400.21/14719 |